M4MM

Tryp Therapeutics Announces Q3 2021 Financial Results

SAN DIEGO–Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today its interim financial results for the three and ...

Subscribe To Our Newsletter